Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aveo Pharmaceuticals (AVEO)

Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 521,445
  • Shares Outstanding, K 34,763
  • Annual Sales, $ 42,300 K
  • Annual Income, $ -53,340 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.00
  • Price/Sales 5.49
  • Price/Cash Flow N/A
  • Price/Book 18.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.84
  • Most Recent Earnings $-0.09 on 11/07/22
  • Next Earnings Date 03/13/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate 0.01
  • Low Estimate -0.09
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +80.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.90 +0.67%
on 12/20/22
15.00 unch
on 01/19/23
+0.09 (+0.60%)
since 12/19/22
3-Month
14.67 +2.25%
on 10/20/22
15.00 unch
on 01/19/23
+0.27 (+1.83%)
since 10/19/22
52-Week
3.06 +390.20%
on 01/28/22
15.00 unch
on 01/19/23
+11.27 (+302.14%)
since 01/19/22

Most Recent Stories

More News
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?

Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.

NBIX : 135.42 (+0.34%)
MDY : 570.23 (+0.72%)
CPRX : 21.27 (-0.89%)
AVEO : 15.00 (unch)
IMCR : 28.33 (-0.33%)
AMGN : 263.38 (+0.84%)
VRTX : 397.27 (+0.16%)
REGN : 701.85 (-0.90%)
GILD : 92.57 (+1.62%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OFIX, AAWW, AVEO, MYOV

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

OFIX : 17.43 (+1.40%)
AAWW : 102.48 (+0.02%)
AVEO : 15.00 (unch)
MYOV : 26.98 (-0.04%)
AVEO: Q3 Earnings Snapshot

AVEO: Q3 Earnings Snapshot

AVEO : 15.00 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVEO, PEBO, LMST, MYOV

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AVEO : 15.00 (unch)
PEBO : 32.24 (+1.07%)
LMST : 23.42 (-1.39%)
MYOV : 26.98 (-0.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LFG, CLR, AVEO, AKUS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

LFG : 26.00 (unch)
CLR : 74.27 (+0.04%)
AVEO : 15.00 (unch)
AKUS : 13.29 (+1.06%)
SHAREHOLDER ALERT: Weiss Law Investigates AVEO Pharmaceuticals, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AVEO Pharmaceuticals,...

AVEO : 15.00 (unch)
AVEO ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AVEO Oncology - AVEO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AVEO Oncology (NasdaqCM: AVEO) to LG Chem,...

AVEO : 15.00 (unch)
Goldman Sachs, Lockheed Martin rise; Hasbro, Conn's fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

AVEO : 15.00 (unch)
AKUS : 13.29 (+1.06%)
MRTN : 15.60 (-1.95%)
GS : 566.10 (+2.19%)
LMT : 489.02 (+1.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKUS, AVEO, LFG, CLR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AKUS : 13.29 (+1.06%)
AVEO : 15.00 (unch)
LFG : 26.00 (unch)
CLR : 74.27 (+0.04%)
Shareholder Alert: Ademi LLP investigates whether AVEO Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with LG Chem

/PRNewswire/ -- Ademi LLP is investigating AVEO (NASDAQ: AVEO) for possible breaches of fiduciary duty and other violations of law in its transaction with LG...

AVEO : 15.00 (unch)

Business Summary

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is...

See More

Key Turning Points

3rd Resistance Point 15.01
2nd Resistance Point 15.01
1st Resistance Point 15.00
Last Price 15.00
1st Support Level 14.99
2nd Support Level 14.99
3rd Support Level 14.98

See More

52-Week High 15.00
Last Price 15.00
Fibonacci 61.8% 10.44
Fibonacci 50% 9.03
Fibonacci 38.2% 7.62
52-Week Low 3.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar